• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C.R. BARD, INC. (BASD) -3006260740 POWERLOC; PORT ACCESS NEEDLE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C.R. BARD, INC. (BASD) -3006260740 POWERLOC; PORT ACCESS NEEDLE Back to Search Results
Model Number N/A
Medical Device Problem Codes Backflow (1064); Defective Component (2292)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 07/12/2025
Type of Reportable Event Malfunction
Event or Problem Description
It was reported, blood is getting trapped at the bifurcation site on powerloc safety infusion set.Despite attempting to flush line beyond what policy states should be required, blood remain trapped in the line.
 
Additional Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The manufacturer has received the sample and will be evaluated.A supplemental will be submitted with evaluation results.
 
Additional Manufacturer Narrative
H11: section a through f - the information provided by bd represents all of the known information at this time.Despite good faith efforts to obtain additional information, the complainant / reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.The complaint of blood remaining in the y-site is confirmed; however, the exact cause is unknown.One photograph of the y-site of an infusion set was returned for evaluation.An initial visual observation of the photograph showed a small amount of blood within the y-site of an infusion set.The blood residue appeared to be located where the stem of the needleless injection cap terminates within the y-site.While the presence of blood in the y-site is confirmed, how and why the residue remained within the device could not be determined.The product ifu states: ¿after therapy completion, flush port per institutional protocol.Close the clamp while injecting the last 0.5 ml of solution.¿ this complaint will be recorded for future trending and monitoring purposes.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
POWERLOC
Common Device Name
PORT ACCESS NEEDLE
Manufacturer (Section D)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city 84116
Manufacturer (Section G)
C.R. BARD, INC. (BASD) -3006260740
605 north 5600 west
salt lake city UT 84116
Manufacturer Contact
yolanda thompson
605 north 5600 west
salt lake city 84116
8015950700
MDR Report Key22701810
Report Number3006260740-2025-05538
Device Sequence Number8945133
Product Code FPA
UDI-Device Identifier00801741047916
UDI-Public(01)00801741047916(11)250321(17)280507(10)ASJYFC024
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
PMA/510(K) Number
K060812
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 08/20/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberN/A
Device Catalogue Number0671934
Device Lot NumberASJYFC024
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer07/21/2025
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/19/2025
Supplement Date Received by Manufacturer08/20/2025
Initial Report FDA Received Date08/04/2025
Supplement Report FDA Received Date09/10/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured03/21/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient SexUnknown
-
-